• +1-646-491-9876
    • +91-20-67278686

    Search

    Ankylosing Spondylitis-Pipeline Review H1 2017

    Ankylosing Spondylitis-Pipeline Review H1 2017

    • Report Code ID: RW0001834322
    • Category Pharmaceuticals
    • No. of Pages 173
    • Publication Month May-17
    • Publisher Name Global Markets Direct
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2017, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline landscape.

    Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 6, 5, 10, 1, 13, 6 and 3 respectively.

    Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) .
    - The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents 2
    List of Tables 5
    List of Figures 6
    Introduction 7
    Publisher Report Coverage 7
    Ankylosing Spondylitis (Bekhterev's Disease) - Overview 8
    Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Development 9
    Pipeline Overview 9
    Pipeline by Companies 10
    Products under Development by Companies 13
    Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment 16
    Assessment by Target 16
    Assessment by Mechanism of Action 18
    Assessment by Route of Administration 20
    Assessment by Molecule Type 22
    Ankylosing Spondylitis (Bekhterev's Disease) - Companies Involved in Therapeutics Development 24
    AbbVie Inc 24
    Adello Biologics LLC 24
    Allergan Plc 25
    Alteogen Inc 25
    Amgen Inc 26
    Biocad 26
    Biocon Ltd 27
    Bionovis SA 27
    Celgene Corp 28
    Coherus BioSciences Inc 28
    Galapagos NV 29
    Genor BioPharma Co Ltd 29
    Immunwork Inc 30
    Innovent Biologics Inc 30
    Johnson & Johnson 31
    Merck KGaA 31
    Momenta Pharmaceuticals Inc 32
    Mycenax Biotech Inc 32
    Novartis AG 33
    Oncobiologics Inc 33
    Protalix BioTherapeutics Inc 34
    Reliance Life Sciences Pvt Ltd 34
    Sandoz International GmbH 35
    Shanghai Pharmaceutical Co Ltd 35
    Sun Pharma Advanced Research Company Ltd 36
    UCB SA 36
    Xbrane Biopharma AB 37
    Ankylosing Spondylitis (Bekhterev's Disease) - Drug Profiles 38
    adalimumab biosimilar - Drug Profile 38
    adalimumab biosimilar - Drug Profile 40
    adalimumab biosimilar - Drug Profile 41
    adalimumab biosimilar - Drug Profile 42
    adalimumab biosimilar - Drug Profile 43
    adalimumab biosimilar - Drug Profile 44
    adalimumab biosimilar - Drug Profile 45
    adalimumab biosimilar - Drug Profile 47
    adalimumab biosimilar - Drug Profile 50
    adalimumab biosimilar - Drug Profile 51
    adalimumab biosimilar - Drug Profile 52
    adalimumab biosimilar - Drug Profile 54
    adalimumab biosimilar - Drug Profile 55
    adalimumab biosimilar - Drug Profile 56
    apremilast - Drug Profile 57
    BAT-1406 - Drug Profile 68
    BCD-085 - Drug Profile 69
    bimekizumab - Drug Profile 70
    certolizumab pegol biosimilar - Drug Profile 72
    DNX-114 - Drug Profile 73
    DNX-514 - Drug Profile 74
    etanercept biosimilar - Drug Profile 75
    etanercept biosimilar - Drug Profile 77
    etanercept biosimilar - Drug Profile 79
    etanercept biosimilar - Drug Profile 80
    etanercept biosimilar - Drug Profile 81
    etanercept biosimilar - Drug Profile 82
    etanercept biosimilar - Drug Profile 86
    etanercept biosimilar - Drug Profile 87
    etanercept biosimilar - Drug Profile 90
    filgotinib - Drug Profile 91
    golimumab - Drug Profile 103
    golimumab biosimilar - Drug Profile 112
    golimumab biosimilar - Drug Profile 113
    HEISCO-III-002 - Drug Profile 114
    infliximab biosimilar - Drug Profile 115
    infliximab biosimilar - Drug Profile 116
    infliximab biosimilar - Drug Profile 117
    infliximab biosimilar - Drug Profile 120
    infliximab biosimilar - Drug Profile 121
    infliximab biosimilar - Drug Profile 122
    infliximab biosimilar - Drug Profile 123
    risankizumab - Drug Profile 124
    secukinumab - Drug Profile 128
    TE-2122 - Drug Profile 141
    TE-2158 - Drug Profile 142
    thalidomide - Drug Profile 143
    tildrakizumab - Drug Profile 144
    upadacitinib tartrate - Drug Profile 147
    VTP-43742 - Drug Profile 151
    Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects 154
    Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products 156
    Ankylosing Spondylitis (Bekhterev's Disease) - Product Development Milestones 157
    Featured News & Press Releases 157
    Appendix 169
    Methodology 169
    Coverage 169
    Secondary Research 169
    Primary Research 169
    Expert Panel Validation 169
    Contact Us 169
    Disclaimer 170

    List of Tables

    Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease) , H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by AbbVie Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Adello Biologics LLC, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Allergan Plc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Alteogen Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Amgen Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocad, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocon Ltd, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bionovis SA, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Celgene Corp, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Coherus BioSciences Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Galapagos NV, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Genor BioPharma Co Ltd, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Immunwork Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Innovent Biologics Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Johnson & Johnson, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Merck KGaA, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Momenta Pharmaceuticals Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mycenax Biotech Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Novartis AG, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Oncobiologics Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Protalix BioTherapeutics Inc, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Reliance Life Sciences Pvt Ltd, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sandoz International GmbH, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Shanghai Pharmaceutical Co Ltd, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by UCB SA, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Xbrane Biopharma AB, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2017 (Contd..1) , H1 2017
    Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease) , H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    AbbVie Inc
    Adello Biologics LLC
    Allergan Plc
    Alteogen Inc
    Amgen Inc
    Biocad
    Biocon Ltd
    Bionovis SA
    Celgene Corp
    Coherus BioSciences Inc
    Galapagos NV
    Genor BioPharma Co Ltd
    Immunwork Inc
    Innovent Biologics Inc
    Johnson & Johnson
    Merck KGaA
    Momenta Pharmaceuticals Inc
    Mycenax Biotech Inc
    Novartis AG
    Oncobiologics Inc
    Protalix BioTherapeutics Inc
    Reliance Life Sciences Pvt Ltd
    Sandoz International GmbH
    Shanghai Pharmaceutical Co Ltd
    Sun Pharma Advanced Research Company Ltd
    UCB SA
    Xbrane Biopharma AB

    Request for Sample

    Report Url http://www.reportsweb.com//ankylosing-spondylitis-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//ankylosing-spondylitis-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//ankylosing-spondylitis-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments